PapersPMID:31249528
The Effects of Curcumin on Weight Loss Among Patients With Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- meta-analysis
What moved
How to read these marks →- Decreases serum leptin
moderatereplicated ×3
“The results showed that curcumin intake among individuals with metabolic diseases significantly reduced leptin (SMD −0.97; 95% CI, −1.18, −0.75; P < 0.001) and increased adiponectin levels (SMD 1.05; 95% CI, 0.23, 1.87; P = 0.01).”
- Effect
- −0.97 standardised mean difference, 95% CI −1.18 to −0.75
- Population
- individuals with metabolic diseases, compared to placebo (pooled meta-analysis)
“Curcumin resulted a significant reduction in BMI (SMD −0.37; 95% CI, −0.61, −0.13; P < 0.01), weight (SMD −0.23; 95% CI, −0.39, −0.06; P < 0.01), and WC levels (SMD −0.25; 95% CI, −0.44, −0.05; P = 0.01).”
- Decreases body mass index
moderatereplicated ×8
- Effect
- −0.37 standardised mean difference, 95% CI −0.61 to −0.13
- Population
- patients with metabolic syndrome and related disorders, compared to placebo (pooled random-effects meta-analysis)
- Decreases body mass
moderatereplicated ×3
- Effect
- −0.23 standardised mean difference, 95% CI −0.39 to −0.06
- Population
- patients with metabolic syndrome and related disorders, compared to placebo (pooled random-effects meta-analysis)
Study record
- Design
- meta-analysis
- Species
- human
- Population
- patients with metabolic syndrome and related disorders
- Participants
- 1,646
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 30
curcumin